Express

A16z Makes First Investment in "DeSci" with Decentralized Biobank Platform AminoChain

Shawn

Summary: Venture capital firm Andreessen Horowitz (a16z) has made its first investment in decentralized science (DeSci) by leading a $5 million seed round for AminoChain, a decentralized biobank platform. AminoChain aims to enhance ownership, transparency, and consent in medical data collection through blockchain technology. The platform will allow medical institutions to share self-custodial data while preserving ...

Venture capital firm Andreessen Horowitz (a16z) has made its first investment in decentralized science (DeSci) by leading a $5 million seed round for AminoChain, a decentralized biobank platform.

AminoChain aims to enhance ownership, transparency, and consent in medical data collection through blockchain technology. The platform will allow medical institutions to share self-custodial data while preserving patient privacy, with the first application being a peer-to-peer marketplace for bio-samples.

Last Update:

Tags: ,,,
Link: A16z Makes First Investment in "DeSci" with Decentralized Biobank Platform AminoChain   [Copy]
Next:

Related Articles

  • ​The Crypto Treasury Boom Meets Regulatory Chill: Is the DAT Frenzy Fading? 7 days ago
  • Nasdaq Takes Aim at 'Crypto-Flipping' Companies with Stricter Rules 11 days ago
  • BTC Weekly Outlook: The Oversold Bounce—A Bottom or a Shorting Opportunity? 13 days ago
  • The Making of a Political Darling: Is Chainlink’s Government Deal a Victory for Tech or... 18 days ago
  • Google Steps Into Blockchain: A New Front in the “Ledger Wars” 19 days ago

    • You need to login to comment.